logo-loader
viewExactus, Inc.

Exactus reports record 1Q revenue on build-out of sales and marketing efforts

The Florida-based firm recorded 1Q revenue of $836,000, versus $15,980 in the prior-year period

Exactus, Inc. - Exactus reports record 1Q revenue on build out of sales and marketing efforts
Exactus also cut its monthly cash burn and shifted focus to generating revenue through bulk specialty ingredient sales 

Exactus Inc (OTCQB:EXDI), a leading supplier of hemp-derived ingredients such as CBD and CBG as well as feminized hemp genetics, reported Wednesday record revenue in the first quarter of 2020. 

In a statement, the company said it recorded 1Q revenue of $836,000, versus $15,980 in the prior-year period. The increase was primarily attributable to the build-out of sales and marketing. 

Exactus also noted that it has significantly cut its monthly cash burn and has shifted its focus to rapidly generate revenue through bulk specialty ingredient sales. 

READ: Exactus appoints executive business leader Julian Pittam to board chairman

Moving into the second half of the year, the Florida-based company said it will begin receiving inventory from its processors, which will expand margins considerably.

"2020 marked a new beginning for Exactus. We are honored to have attracted some incredible new additions to our board of directors with significant banking, media, and technology backgrounds that are fully aligned with our M&A and organic growth strategies,” said Interim CEO Emiliano Aloi.

Aloi also praised Exactus president Derek Du Chesne’s “valuable work in restructuring our commercial and supply chain strategies,” which has prompted the higher revenues and lower spending. 

“Considering the market conditions surrounding COVID-19, we are pleased to have made significant progress building the infrastructure of our sales and marketing division to scale in this rapidly evolving industry,” said Du Chesne.

“As we continue to stay ahead of this ever-changing landscape, I believe that Exactus is uniquely positioned for longevity and success. It is a pivotal time in this industry and as our business grows, we are looking forward to opportunities in high-value mergers and acquisitions to consolidate processing and brands under the Exactus umbrella.”

Meanwhile, the company reported a 1Q net loss of $2,945,503, versus $1,409,867 million in the prior-year quarter. The loss was due primarily to non-cash expenses for stock-based compensation, Exactus added. 

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

 

Quick facts: Exactus, Inc.

Price: 0.075 USD

OTCQB:EXDI
Market: OTCQB
Market Cap: $3.72 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Exactus, Inc. named herein, including the promotion by the Company of Exactus, Inc. in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Exactus off to a great start in 2020 signing a number of Hemp contracts

Exactus (OTCQB: EXDI) President Derek Du Chesne joined Steve Darling from Proactive with news the company is seeing a strong start to 2020 with new customers signing purchase orders. Du Chesne also told Proactive about their new hemp buyback program that was put in place to help farmers...

on 06/09/2020

2 min read